The clinical research as a care option movement advances with yet another important but not well publicized deal involving Messino […]
POINT Acquires exclusive rights to breakthrough pan-cancer treatment TORONTO and BOSTON, Nov. 10, 2020 (GLOBE NEWSWIRE) — POINT Biopharma Inc. […]
A U.S. biotech company called Equillium, Inc. recently received a Study May Proceed letter from the U.S. Food and Drug […]
CEPI, the Coalition for Epidemic Preparedness Innovations, today announced that it will fund the development of the protein-based S-Trimer COVID-19 […]
NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused […]
Daina Graybosch, a top life science research analyst at SVB Leerink covering Immuno-Oncology, recently communicated to investors that Pfizer and partner […]
The Woodruff Health Sciences Center (WHSC) at Emory University recently named its latest Synergy Award winners: all ten selected projects […]
Foundation Medicine, Inc. and OneOncology announced today, August 17th, 2020, a new joint initiative that is intended to better enable […]
By September 2018, Javara and Wake Forest Baptist Health announced their intention to deliver the clinical research as a care option […]
Welcome To Investor Watch In this series will be going over trials, research and other clinical verticals that receive funding. […]
